22157.jpg
Global Acute Myeloid Leukemia (AML) Disease Analysis Report 2021: On Average, it Takes 10.8 Years from Phase I to Approval, Compared to 9.6 Years in the Overall Oncology Space
12 avr. 2021 06h48 HE | Research and Markets
Dublin, April 12, 2021 (GLOBE NEWSWIRE) -- The "Disease Analysis: Acute Myeloid Leukemia (AML)" report has been added to ResearchAndMarkets.com's offering. AML is a type of heterogeneous...
22157.jpg
Outlook on the Chronic Myeloid Leukemia (CML) Treatment Global Market to 2029 - by Treatment Type and Geography
30 mars 2021 07h48 HE | Research and Markets
Dublin, March 30, 2021 (GLOBE NEWSWIRE) -- The "Chronic Myeloid Leukemia (CML) Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive...
22157.jpg
World Outlook for the Microfluidic Devices Market - A US$ 22.65 Billion Market by 2026
02 févr. 2021 02h53 HE | Research and Markets
Dublin, Feb. 02, 2021 (GLOBE NEWSWIRE) -- The "Global Microfluidic Devices Market (by Device Type, Material, Application, Industry, Geography), Impact of COVID-19, Company Profiles and Recent...
22157.jpg
Global Pathogen Reduction Systems Market Report 2020-2025: Recent Outbreak of COVID-19 is Expected to Drive the Demand for These Systems
11 nov. 2020 02h53 HE | Research and Markets
Dublin, Nov. 11, 2020 (GLOBE NEWSWIRE) -- The "Global Pathogen Reduction Systems Market, By Type, By Application, By Product, By End User, By Region, Competition, Forecast & Opportunities, 2025"...
22157.jpg
Global Hematology and Coagulation Testing Markets Report 2020 with Discussion of COVID-19
28 oct. 2020 06h53 HE | Research and Markets
Dublin, Oct. 28, 2020 (GLOBE NEWSWIRE) -- The "Hematology and Coagulation Markets (Lab-based and Decentralized Markets)" report has been added to ResearchAndMarkets.com's offering. Hematology and...